Skip to main content

Correction to: In vitro assessment of nutraceutical compounds and novel nutraceutical formulations in a liver-steatosis-based model

The Original Article was published on 05 February 2018

Correction to: Lipids Health Dis 17, 24 (2018)

https://doi.org/10.1186/s12944-018-0663-2

Following the publication of the original article [1], the authors noticed an inaccuracy related to western blotting actin bands in Figs. 5 and 6.

In this respect, the authors apologize for uploading the western blotting (actins bands) that could be misleading. The actins obtained for the filters incubated for SOD-2 antibody were incorrectly duplicated for filters incubated with PPAR-γ. Presented here are the correct Figs. 5 and 6 with the correct actins references.

Fig. 5
figure 1

a, b Western blot relative to SOD-2 as a marker of oxidative stress. Actin is used to normalize the results. All values were expressed in the form of mean ± SD (n = 3)

Fig. 6
figure 2

PPARα and PPARγ protein expression levels on HepG2 cells determined by Western blotting. Actin is used to normalize the results

Reference

  1. Stellavato A, Pirozzi AVA, de Novellis F, et al. In vitro assessment of nutraceutical compounds and novel nutraceutical formulations in a liver-steatosis-based model. Lipids Health Dis. 2018;17:24. https://doi.org/10.1186/s12944-018-0663-2.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chiara Schiraldi.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Stellavato, A., Pirozzi, A.V.A., de Novellis, F. et al. Correction to: In vitro assessment of nutraceutical compounds and novel nutraceutical formulations in a liver-steatosis-based model. Lipids Health Dis 21, 37 (2022). https://doi.org/10.1186/s12944-022-01646-6

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12944-022-01646-6